Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Newer insulins 'no more effective'

  • Comment
The long-acting insulin NPH is as effective in treating type 2 diabetes as newer, more expensive kinds of insulin, such as glargine or detemir, according to a Cochrane review.

The long-acting insulin NPH is as effective in treating type 2 diabetes as newer, more expensivekinds of insulin, such as glargine or detemir, according to a Cochrane review.

Researchers looked at eight studies of between 24 and 52 weeks, involving 2,293 patients. They found that insulin glargine or insulin detemir were almost identical to NPH in lowering levels of HbA1c.

The newer insulins, however, caused fewer problems with low blood glucose while patients were sleeping.

Cochrane Database of Systematic Reviews (2007) 2
www.cochrane.org

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.